Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.

about

PRAME expression and promoter hypomethylation in epithelial ovarian cancer.Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.Systematic identification of cancer-specific MHC-binding peptides with RAVEN

P2860

Q37564420-64BD5F92-47B1-4919-87F9-646E97149363 Q37644842-812E5E84-904E-4C56-9FAE-1E2765AA0882 Q56875164-58E19E7E-A1F1-4CDF-9E7E-7F1A91609D17

P2860

Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.

Item

http://www.wikidata.org/entity/Q38262786

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.

@en

type

Item

label

Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.

@en

prefLabel

Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.

@en

P1476

Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.

@en

P2093

Dirk M van der Steen

http://www.w3.org/2001/XMLSchema#string

Jan J Molenaar

http://www.w3.org/2001/XMLSchema#string

Lotte Spel

http://www.w3.org/2001/XMLSchema#string

Max M van Noesel

http://www.w3.org/2001/XMLSchema#string

Mirjam H M Heemskerk

http://www.w3.org/2001/XMLSchema#string

Nina J G Blokland

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive immunotherapy for cancer: building on success

Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

Chimeric antigen receptor therapy for cancer

The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells

The three Es of cancer immunoediting

The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

Cancer immunotherapy comes of age

Immune-mediated complications during interferon therapy in hematological patients.

P304

35770-35781

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.5657

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jaap J. Boelens

Stefan Nierkens

Marianne Boes

P577

2015-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282764578

http://www.w3.org/2001/XMLSchema#string

P698

26452036

http://www.w3.org/2001/XMLSchema#string

P932

4742140

http://www.w3.org/2001/XMLSchema#string

Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.

about

P2860

P2860

Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932